Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Heron Therapeutics Inc
F:AXD2
Heron Therapeutics Inc
F:AXD2
Price:
0.3336
EUR
12.25%
Market Closed
Market Cap:
€50.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Heron Therapeutics Inc
F:AXD2
|
US |
|
BW LPG Ltd
OSE:BWLPG
|
SG |
|
AECI Ltd
F:A7Z
|
ZA |
|
Bhansali Engg Polymers Ltd
BSE:500052
|
IN |
|
R
|
Rural Funds Group
OTC:RFNDF
|
AU |
|
Bankwell Financial Group Inc
F:33W
|
US |
|
B
|
Business Engineering Corp
XMUN:TBY
|
JP |
|
D
|
Douglas Elliman Inc
F:8OT
|
US |
|
C
|
Credit Acceptance Corp
F:2D5
|
US |
|
A
|
AMAG Austria Metall AG
XMUN:AM8
|
AT |
|
C
|
Cracker Barrel Old Country Store Inc
XMUN:OLD
|
US |
|
T
|
TUGA Innovations Inc
F:DQ5
|
CA |
|
Genoway SA
F:JEH
|
FR |
|
Karbon Capital Partners Corp
NASDAQ:KBON
|
US |
|
B
|
Byggma ASA
OSE:BMA
|
NO |
|
W
|
Webuild SpA
DUS:IPJ1
|
IT |
|
S
|
Springer Nature AG & Co KgaA
F:SPG
|
DE |
|
T
|
transcosmos Inc
XMUN:TSQ
|
JP |
|
G
|
G-III Apparel Group Ltd
F:GI4
|
US |
|
C
|
Cloudbreak Discovery PLC
OTC:CDBDF
|
UK |
|
F
|
Fab Form Industries Ltd
XTSX:FBF
|
CA |
|
A
|
Arcticzymes Technologies ASA
SWB:B4V
|
NO |
|
D
|
Defence Therapeutics Inc
F:DTC
|
CA |
|
M
|
Mindax Ltd
ASX:MDX
|
AU |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AXD2's stock price target?
Not Available
AXD2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Heron Therapeutics Inc?
Projected CAGR
12%
12%
The compound annual growth rate for Revenue over the next 5 years is 12%.
What is the Gross Profit forecast for Heron Therapeutics Inc?
Projected CAGR
13%
13%
The compound annual growth rate for Gross Profit over the next 5 years is 13%.